<DOC>
	<DOCNO>NCT02626520</DOCNO>
	<brief_summary>Patients diagnose pancreatic cancer without clinically detectable metastatic disease treat standardized systemic chemotherapy , follow chemoradiation , surgical resection resectable borderline resectable disease . The primary endpoint disease-free survival 1 yr initiation treatment .</brief_summary>
	<brief_title>Phase 2 Evaluation Multi-modality Algorithm Non-metastatic Adenocarcinoma Pancreas Ampulla</brief_title>
	<detailed_description>Patients ductal adenocarcinoma pancreas ( ampulla ) receive prior therapy clinically detectable metastatic disease enrol . Management driven resectability status define American College Surgeons . All patient define entry Resectable , Borderline Resectable Locally Advanced ( Unresectable ) . All patient treat initially gemcitabine nanoparticle albumin bound paclitaxel ( nab-paclitaxel ) every 14 day 4 cycle . Patients classify Resectable , CA19-9 180 CA-125 30 proceed resection . All patient get 5-fluorouracil 46 hr infusion give leucovorin irinotecan ( FOLFIRI-3 ) every 14 day x 4 cycle . All patient without progression receive chemoradiation consist external beam radiotherapy ( 40 Gy 20 fraction give 4 week ) . During radiation patient receive radiosensitizing radiotherapy : 5-fluorouracil 225 mg/m2 5 day per week , Mitomycin-C 3 mg.m2 d1 , 8 , 15 &amp; 22 ; Cisplatin 10 mg/m2 d2 , 9 , 16 , 23 unfractionated heparin 6,000 units/m2 daily divide dos day 1 day 28 . After approximately 4 week recover chemoradiation , patient Resectable Borderline Resectable disease undergo definitive surgery . Adjuvant therapy FOLFIR-3 additional 6 cycle offer patient post-operatively . Patients actively follow every 3 6 month keep National Comprehensive Cancer Network ( NCCN ) guideline 2 yr , follow recurrence , late toxicity vital status every 6 month 5 year .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>Histologic proof adenocarcinoma consistent ductal carcinoma pancreas ampulla , evidence metastatic disease clinical exam crosssectional imaging . Fitness chemotherapy judgement treat physician Bilirubin &lt; 4 ( mean biliary drainage acceptable ) Medical mental illness preclude provision inform consent Pregnancy Active infection neutropenia would pose high risk mortality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>